These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1305736)

  • 1. [Pefloxacin in the treatment of chronic urinary infection].
    Jeromin L; Sosnowski M; Dutkiewicz W; Kuligowski W
    Pol Tyg Lek; 1992 Dec 7-14; 47(49-50):1105-7. PubMed ID: 1305736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with pefloxacin in patients with urinary tract infections.
    Chan PC; Cheng IK; Chan MK; Wong WT
    Br J Clin Pract; 1990 Dec; 44(12):564-7. PubMed ID: 2102145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of minimum inhibitory concentration values for fluoroquinolones against Escherichia coli causing urinary tract infection in both hospitalized patients and outpatients.
    Tayfour M; Yuce A; Yulug N
    Saudi Med J; 2001 Oct; 22(10):848-51. PubMed ID: 11744939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and tolerance of pefloxacin in the treatment of complicated urinary tract infections in Tunisia].
    Ayed M
    Tunis Med; 1992 Nov; 70(11):541-6. PubMed ID: 1295170
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of pefloxacin in the treatment of postoperative sepsis in gynaecology.
    Arowojolu AO; Bakare RA; Oni AA; Ayodele AE; Kayode OO
    Afr J Med Med Sci; 1999; 28(3-4):151-3. PubMed ID: 11205820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of recent bacterial isolates to cefdinir and selected antibiotics among children with urinary tract infections.
    Bonsu BK; Shuler L; Sawicki L; Dorst P; Cohen DM
    Acad Emerg Med; 2006 Jan; 13(1):76-81. PubMed ID: 16365328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pefloxacin in the treatment of recurrent urinary tract infections].
    Oksa A; Dzúriková V; Gajdos M; Krechnáková A; Krivosíková G; Ploczeková C; Spustová V
    Cas Lek Cesk; 1990 Jul; 129(30):953-6. PubMed ID: 2208227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at Tikur Anbessa Specialized Hospital Addis Ababa, Ethiopia.
    Assefa A; Asrat D; Woldeamanuel Y; G/Hiwot Y; Abdella A; Melesse T
    Ethiop Med J; 2008 Jul; 46(3):227-35. PubMed ID: 19271386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing incidence of bacterial, resistance to antibiotics by isolates from the urinary tract.
    Ozumba UC
    Niger J Clin Pract; 2005 Dec; 8(2):107-9. PubMed ID: 16477864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of norfloxacin preparation in treatment of bacterial infections of the urinary tract in patients with various kidney diseases].
    Mazanowska O; Boratyńska M; Mróz E; Starek J
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):154-7. PubMed ID: 8090671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiologies of the urinary tract infections in a Yemeni City.
    Nasher MA; Nasher TM; Gunaid AA
    Saudi Med J; 2001 Jul; 22(7):599-602. PubMed ID: 11479641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial sensitivity pattern in urinary tract infections in children: a single center experience of 1,177 urine cultures.
    Sharifian M; Karimi A; Tabatabaei SR; Anvaripour N
    Jpn J Infect Dis; 2006 Dec; 59(6):380-2. PubMed ID: 17186957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The in vitro activity of ofloxacin, pefloxacin and ciprofloxacin against various gram negative bacteria isolated from urinary tract infections].
    Tunçkanat F; Yuluğ N
    Mikrobiyol Bul; 1988; 22(3):187-92. PubMed ID: 3252111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and susceptibility profile of pathogens causing urinary tract infections at a tertiary care hospital in western Nepal.
    Das RN; Chandrashekhar TS; Joshi HS; Gurung M; Shrestha N; Shivananda PG
    Singapore Med J; 2006 Apr; 47(4):281-5. PubMed ID: 16572238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro sensitivity of 39 strains of Pseudomonas aeruginosa isolated from urine culture of hospitalized patients].
    Vanni M; Zucca C
    Minerva Med; 1986 Jun; 77(27):1289-92. PubMed ID: 3088493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of norfloxacin in the treatment of urinary tract infections in Tikure Anbessa Hospital, Addis Ababa, Ethiopia.
    Mengesha B
    East Afr Med J; 1991 Nov; 68(11):844-52. PubMed ID: 1800077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of continuous bacteriological control for the therapy of chronic urinary tract infections].
    Hensel K; Gruhn I; Schneider HJ; Klinger G
    Z Urol Nephrol; 1974 Jul; 67(7):539-41. PubMed ID: 4613059
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of sensitivity to antibiotics of microorganisms isolated from children with urinary tract infections].
    Cisowska A; Lewczyk E; Korzekwa K; Wojnicz D; Jankowski S; Doroszkiewicz W
    Pol Merkur Lekarski; 2003 Apr; 14(82):322-6. PubMed ID: 12868193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the sensitivity to pipemidic acid, pefloxacin and norfloxacin of 444 bacterial strains isolated at a general hospital].
    Berardi-Grassias LD; Roy O
    Pathol Biol (Paris); 1987 May; 35(5):467-72. PubMed ID: 3112705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.